Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Cyprus
Cyprus: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 0.5% in 2024. ▼ Falling
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Cyprus, 2015–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
In 2024, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Cyprus stood at 0.5%. That is the lowest value across all 10 years on record.
Compared with earlier readings it is down 16.7% over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Cyprus peaked at 0.6% in 2015 and was at its lowest, 0.5%, in 2020.
Cyprus ranks 56th of 215 countries on this measure, in the middle of the range.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Cyprus, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0.6% | — |
| 2016 | 0.6% | +0.0% |
| 2017 | 0.6% | +0.0% |
| 2018 | 0.6% | +0.0% |
| 2019 | 0.6% | +0.0% |
| 2020 | 0.5% | -16.7% |
| 2021 | 0.5% | +0.0% |
| 2022 | 0.5% | +0.0% |
| 2023 | 0.5% | +0.0% |
| 2024 | 0.5% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.6% | 0.6% | 0.6% | 5 |
| 2020s | 0.5% | 0.5% | 0.5% | 5 |
Countries ranked near Cyprus
More development goals data for Cyprus
- Red List Index 0.8363 (2025)
- Number of refugees per 100,000 population, by country of origin 0.7295 (2025)
- Manufacturing value added per capita 1,072 (2025)
- Number of transboundary breeds 13 (2025)
- Number of transboundary breeds (not extinct) 12 (2025)
- Number of transboundary breeds with unknown risk status 8 (2025)
- Number of local breeds with unknown risk status 13 (2025)
- Number of local breeds (not extinct) 16 (2025)
- Number of local breeds kept in the country 17 (2025)
- Infant deaths 59 (2024)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Cyprus?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Cyprus was 0.5% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Cyprus?
- The highest recorded value was 0.6% in 2015.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Cyprus?
- The lowest recorded value was 0.5% in 2020.
- How does Cyprus rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Cyprus ranks 56th out of 215 countries with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Cyprus?
- Over the last ten years it is down 16.7%. The long-run trend across the full record is falling.
- Where does this Cyprus data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).